| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.26T | 7.58T | 7.08T | 6.31T | 5.75T | 5.32T |
| Gross Profit | 8.26T | 6.57T | 6.13T | 5.46T | 5.00T | 4.63T |
| EBITDA | 3.95B | 1.71T | 1.06T | 726.82B | 724.58B | 397.33B |
| Net Income | 1.32T | 1.06T | 695.81B | 374.61B | 420.48B | 161.80B |
Balance Sheet | ||||||
| Total Assets | 30.56T | 31.24T | 30.59T | 27.70T | 27.25T | 25.77T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.07T | 896.90B | 871.99B | 848.82B | 812.01B |
| Total Debt | 225.76B | 227.25B | 224.40B | 222.81B | 219.79B | 230.60B |
| Total Liabilities | 25.64T | 26.13T | 25.41T | 24.04T | 23.17T | 22.04T |
| Stockholders Equity | 4.94T | 5.08T | 5.18T | 3.63T | 4.02T | 3.67T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.32T | 1.05T | 982.71B | 1.07T | 1.15T |
| Operating Cash Flow | 0.00 | 1.35T | 1.07T | 1.01T | 1.10T | 1.18T |
| Investing Cash Flow | 0.00 | 164.62B | -627.65B | 18.19B | -665.44B | -731.01B |
| Financing Cash Flow | 0.00 | -1.19T | -406.20B | -1.01T | -504.63B | -512.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $55.96B | 5.47 | 42.71% | 1.91% | 4.40% | 209.62% | |
82 Outperform | $63.74B | 9.17 | 24.14% | 1.49% | 4.12% | 83.05% | |
79 Outperform | $90.76B | 12.77 | 20.81% | 3.26% | 3.77% | 2.49% | |
78 Outperform | $125.72B | 13.86 | 15.65% | 1.22% | 8.26% | 35.89% | |
77 Outperform | $24.74B | 12.62 | 19.48% | 1.88% | 6.61% | 9.14% | |
74 Outperform | $116.71B | 10.30 | 35.45% | 2.20% | 13.89% | 32.56% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |